"Over 200 patients now pre-screened, with rate of patient dosing expected to increase due to significant early engagement and ongoing support from Emerald Clinics."
Sounds like the dates provided in the trial registry ANZCTR would be worst case scenario and the language in this announcement means we will be ahead of schedule.
Ann: First dosing commenced for pivotal EMD-RX5 Phase 3 trial, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.9¢ |
Change
0.001(3.57%) |
Mkt cap ! $17.73M | |||
| Open | High | Low | Value | Volume |
| 2.9¢ | 3.0¢ | 2.8¢ | $71.48K | 2.457M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 120800 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.0¢ | 1018286 | 4 |
View Market Depth
| Last trade - 15.42pm 15/07/2025 (20 minute delay) ? |
| EMD (ASX) Chart |